The drug distributed cash dividends of 53.5 million riyals for the third quarter of 2025

The drug distributed cash dividends of 53.5 million riyals for the third quarter of 2025

04.02.2026
6 mins read
Al-Dawaa Medical Services Company announced the distribution of cash dividends worth 53.5 million riyals to shareholders for the third quarter of 2025, at a rate of 0.63 riyals per share.

Earnings announcement boosts investor confidence

Al-Dawaa Medical Services Company (DMSCO), one of the leading companies in the pharmacy and pharmaceutical retail sector in the Kingdom of Saudi Arabia, announced the decision of its Board of Directors to distribute cash dividends to shareholders for the third quarter of the fiscal year ending on December 31, 2025. This announcement reflects the company's strong financial performance and its ability to achieve worthwhile returns for its investors.

In an official statement published on the Saudi Stock Exchange (Tadawul), the company clarified that the total amount to be distributed is SAR 53.5 million. This amount will be distributed across 85 million shares eligible for dividends, resulting in a dividend of SAR 0.63 per share. The company added that this dividend represents a distribution rate of 6.3% of the share's nominal value, which is a positive indicator of the company's policy of sharing its profits with shareholders.

General context and importance of the pharmaceutical company in the Saudi market

Founded in 1993, Al-Dawaa Medical Services Company has grown to become one of the largest pharmacy chains in the Kingdom, with an extensive network of branches covering various regions. The company's role extends beyond retail pharmaceuticals to include cosmetics and personal care products, making it a comprehensive destination for consumers. Following its listing on the Saudi Stock Exchange (Tadawul), the company gained further momentum, providing investors with the opportunity to participate in the growth of one of the most vital sectors related to healthcare, a sector experiencing increasing growth in line with the Kingdom's Vision 2030 goals for developing the health sector.

Expected impact, eligibility details, and distribution

The decision to distribute dividends not only benefits current shareholders but also sends a strong message to the financial market about the company's financial stability and confidence in its future performance. Such announcements contribute to enhancing the attractiveness of the company's stock to both local and international investors and support its price stability in the market. The company has set February 10th as the dividend entitlement date, meaning that shareholders registered in the company's records at the close of trading on that day are entitled to these distributions. The process of depositing dividends into shareholders' accounts is scheduled to begin on February 25th, ensuring that the returns reach eligible shareholders in a clear and timely manner.

Leave a comment

Your email address will not be published.

Go up